×

Phosphate and thiophosphate protecting groups

  • US 6,610,837 B1
  • Filed: 03/16/2000
  • Issued: 08/26/2003
  • Est. Priority Date: 03/16/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for the preparation of an oligonucleotide compound containing one or more moieties having Formula X:

  • embedded imagewherein;

    each W and X is, independently, O or S;

    Y is O or NR2;

    Z is a single bond, O or NR2a;

    each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;

    or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;

    each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;

    each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;

    or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered, heterocarbocyclic ring containing one nitrogen atom in the ring;

    each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;

    or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;

    R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;

    each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl; and

    each n and m is, independently, 0, 1, 2 or 3; and

    comprising;

    (a) providing a compound of Formula II;

    embedded imagewhereinR6 is H, a hydroxyl protecting group or a linker connected to a solid support;

    R7 is H, hydroxyl, C1-20 alkyl, C3-20 alkenyl, C2-20 alkynyl, halogen, SR7a wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;

    keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O—

    C1-20 alkyl, NH—

    C1-20 alkyl, N-diC1-20 alkyl, O-aryl, S-aryl, NH-aryl, O—

    C1-20 aralkyl, S—

    C1-20 aralkyl, NH—

    C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;

    embedded imagewherein;

    E is C1 to C10 alkyl, N(R15)(R17) and N═

    C(R15)R17);

    each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group, or a linker to a solid support;

    or R15 and R17, together, are form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;

    each q1 and q2 is, independently, an integer from 1 to 10;

    R16 is OR18, SR18, or N(R18)2;

    R18 is H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═

    NH)N(H)R19, C(═

    O)N(H)R19 or OC(═

    O)N(H)R19;

    R19 is H or C1 to C8 alkyl;

    L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 1 or 2 heteroatoms wherein each of said heteroatoms is, independently, oxygen, nitrogen or sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;

    L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17)OR15, halo, SR15 or CN;

    q4 is 0, 1 or 2;

    R8 is NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S;

    each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;

    X1 is O or S;

    each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;

    q is an integer from 1 to 10;

    p is 0 or an integer from 1 to about 50;

    each Q is, independently, OH, SH or embedded image(b) reacting the compound of Formula II with a compound of Formula III;

    embedded imagewherein;

    R10 is a hydroxyl protecting group or a linker connected to a solid support;

    with the provisos that R6 and R10 are not both simultaneously a linker connected to a solid support;

    p′

    is 0 or an integer from 1 to about 50; and

    either;

    1) at least one n is other than zero and at least one R3a is other than hydrogen wherein one of the central carbons of the group (R3a

    C)n

    C(R3)2 is said chiral atom;

    or 2) at least one moiety of Formula X contains a chiral atom;

    to form said oligonucleotide compound.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×